Abstract: This application provides a kit or a device for detection of lung cancer, comprising a nucleic acid(s) for detecting a miRNA(s) in a sample from a subject, and a method for detecting lung cancer, comprising measuring the miRNA(s) in vitro.
Type:
Grant
Filed:
June 29, 2018
Date of Patent:
April 25, 2023
Assignees:
TORAY INDUSTRIES, INC., NATIONAL CANCER CENTER
Abstract: It is intended to provide a kit or a device for the detection of esophageal cancer and a method for detecting esophageal cancer. The present invention provides a kit or a device for the detection of esophageal cancer, comprising nucleic acid(s) capable of specifically binding to miRNA(s) in a sample of a subject, and a method for detecting esophageal cancer, comprising measuring the miRNA in vitro.
Type:
Application
Filed:
November 18, 2022
Publication date:
April 20, 2023
Applicants:
TORAY INDUSTRIES, INC., NATIONAL CANCER CENTER
Abstract: It is intended to provide a kit or device for the detection of liver cancer and a method for detecting liver cancer. The present invention relates to a kit or device for the detection of liver cancer, comprising a nucleic acid capable of specifically binding to miRNA in a sample of a subject, and a method for detecting liver cancer, comprising measuring the miRNA in vitro.
Type:
Application
Filed:
October 21, 2022
Publication date:
April 6, 2023
Applicants:
TORAY INDUSTRIES, INC., NATIONAL CANCER CENTER
Abstract: It is intended to provide a kit or a device for the detection of colorectal cancer and a method for detecting colorectal cancer. The present invention provides a kit or a device for the detection of colorectal cancer, comprising a nucleic acid capable of specifically binding to a miRNA in a sample from a subject, and a method for detecting colorectal cancer, comprising measuring the miRNA in vitro.
Type:
Application
Filed:
September 15, 2022
Publication date:
April 6, 2023
Applicants:
TORAY INDUSTRIES, INC., NATIONAL CANCER CENTER
Abstract: It is intended to provide a kit or a device for the detection of breast cancer and a method for detecting breast cancer. The present invention provides a kit or a device for the detection of breast cancer, comprising nucleic acid(s) capable of specifically binding to a miRNA in a sample of a subject, and a method for detecting breast cancer, comprising measuring the miRNA in vitro.
Type:
Application
Filed:
September 14, 2022
Publication date:
March 23, 2023
Applicants:
TORAY INDUSTRIES, INC., NATIONAL CANCER CENTER
Abstract: The present invention relates to a monoclonal antibody or antigen-binding fragment thereof that specifically binds to TIM-3 and uses thereof. The monoclonal antibody, hTIM-3_NCC1, of the present invention specifically recognizes human and mouse cells expressing TIM-3, and it can be useful for various fields such as diagnosis of diseases mediated by TIM-3 expressing cells as well as prevention or treatment thereof.
Abstract: The present invention provides a kit or device for the detection of biliary tract cancer, and a method for detecting biliary tract cancer. The present invention relates to a kit or device for the detection of biliary tract cancer, comprising a nucleic acid capable of specifically binding to miRNA in a sample of a subject, and a method for detecting biliary tract cancer, comprising measuring the miRNA in vitro.
Type:
Application
Filed:
September 8, 2022
Publication date:
March 23, 2023
Applicants:
TORAY INDUSTRIES, INC., NATIONAL CANCER CENTER
Abstract: A suture method includes a first arrangement step of using a first treatment device including first/second grasping pieces to hook the first grasping piece to a first position of peripheral tissues of a lesion; a second arrangement step of hooking the second grasping piece to a second position of the peripheral tissues; a grasping step of grasping the first position and the second position while pressing the first position and the second position to the peripheral tissues; a retracting step of retracting the lesion site toward a proximal end side of the first treatment device while drawing the first position and the second position grasped by the first treatment device; and a suturing step of suturing a first suturing position at an external side of the first position and a second suturing position at an external side of the second position in the peripheral tissues.
Type:
Application
Filed:
September 10, 2021
Publication date:
March 16, 2023
Applicants:
OLYMPUS CORPORATION, NATIONAL CANCER CENTER
Inventors:
Chisato KARASAWA, Satoru NONAKA, Ichiro ODA
Abstract: Provided is a T cell receptor capable of binding to a peptide having the amino acid sequence shown in SEQ ID NO: 27 or a complex of the peptide and HLA-A24. A T cell receptor capable of binding to a peptide having the amino acid sequence shown in SEQ ID NO: 28 or a complex of the peptide and HLA-A02. Disclosed T cell receptors are useful in treating or avoiding cancers which are associated with expression of glypican-3.
Type:
Grant
Filed:
February 5, 2018
Date of Patent:
March 14, 2023
Assignees:
National Cancer Center Japan, Kyoto University, Takeda Pharmaceutical Company Limited
Abstract: A method for producing a professional antigen-presenting cell, including inducing expression of c-MYC, BMI1, and MDM2 in a myeloid cell (MC) to obtain a proliferative myeloid cell (pMC), and inducing expression of GM-CSF and/or M-CSF in the pMC to obtain a professional antigen-presenting cell (pAPC). The myeloid cell is a myeloid cell differentiated from a pluripotent stem cell.
Type:
Application
Filed:
November 10, 2022
Publication date:
March 9, 2023
Applicants:
AGC INC., National Cancer Center Japan
Abstract: An information processing apparatus (2000) detects an abnormal region (30) from a predetermined range (16) of a video frame (14). The information processing apparatus (2000) determines whether a predetermined condition is satisfied in a case where the abnormal region (30) is detected from the predetermined range (16) of a certain video frame (14) and the abnormal region (30) is not detected from the predetermined range (16) of a predetermined video frame (14) generated later than the video frame (14). In a case where the predetermined condition is not satisfied, the information processing apparatus (2000) performs a predetermined notification.
Type:
Grant
Filed:
May 18, 2018
Date of Patent:
January 17, 2023
Assignees:
NEC CORPORATION, NATIONAL CANCER CENTER
Abstract: Disclosed is a kit or a device for the detection of stomach cancer and a method for detecting stomach cancer, and provides a kit or a device for the detection of stomach cancer, including a nucleic acid(s) capable of specifically binding to a miRNA(s) in a sample from a subject, and a method for detecting stomach cancer, including measuring the miRNA(s) in vitro.
Type:
Application
Filed:
September 20, 2022
Publication date:
January 5, 2023
Applicants:
TORAY INDUSTRIES, INC., NATIONAL CANCER CENTER
Abstract: It is intended to provide a kit or a device for the detection of esophageal cancer and a method for detecting esophageal cancer. The present invention provides a kit or a device for the detection of esophageal cancer, comprising nucleic acid(s) capable of specifically binding to miRNA(s) in a sample f a subject, and a method for detecting esophageal cancer, comprising measuring the miRNA in vitro.
Type:
Grant
Filed:
February 27, 2020
Date of Patent:
January 3, 2023
Assignees:
TORAY INDUSTRIES, INC., NATIONAL CANCER CENTER
Abstract: This invention provides a kit or device for detection of prostate cancer and a method for detecting prostate cancer. This invention provides a kit or device for detection of prostate cancer comprising a nucleic acid capable of specifically binding to an miRNA in a sample from a subject or a complementary strand thereof and a method for detecting prostate cancer comprising measuring the miRNA in vitro.
Type:
Grant
Filed:
August 9, 2019
Date of Patent:
December 27, 2022
Assignees:
TORAY INDUSTRIES, INC., NATIONAL CANCER CENTER
Abstract: There is disclosed a non-transitory computer-readable recording medium having stored therein an information processing program for causing a computer to execute a process.
Type:
Application
Filed:
May 27, 2022
Publication date:
December 15, 2022
Applicants:
FUJITSU LIMITED, RIKEN, NATIONAL CANCER CENTER
Abstract: A non-transitory computer-readable recording medium has stored therein an evaluating program for causing a computer to execute a process including: specifying a wall of an inspection target in two or more moving images being obtained by photographing two types of cross sections of the inspection target, the two types of cross sections being orthogonal to each other; evaluating photographing quality of each of a plurality of first divisional regions obtained by dividing a region corresponding to the wall specified in a first image related to a first cross section among the two or more moving images; and evaluating photographing quality of each of a plurality of second divisional regions obtained by dividing a region corresponding to the wall specified in a second image related to a second cross section among the two or more moving images, the second cross section being different from the first cross section.
Type:
Application
Filed:
May 27, 2022
Publication date:
December 15, 2022
Applicants:
FUJITSU LIMITED, RIKEN, National University Corporation Tokyo Medical and Dental University, NATIONAL CANCER CENTER
Abstract: An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
Type:
Grant
Filed:
September 23, 2019
Date of Patent:
December 13, 2022
Assignees:
National Cancer Center, RIN Institute Inc.
Abstract: It is intended to provide a kit or a device for the detection of lung cancer and a method for detecting lung cancer. The present invention provides a kit or a device for the detection of lung cancer, comprising a nucleic acid capable of specifically binding to a miRNA in a sample from a subject, and a method for detecting lung cancer, comprising measuring the miRNA in vitro.
Type:
Grant
Filed:
February 25, 2020
Date of Patent:
December 6, 2022
Assignees:
TORAY INDUSTRIES, INC., NATIONAL CANCER CENTER
Abstract: An object of the present invention is to provide a kit or a device for the detection of prostate cancer and a method for detecting prostate cancer. The present invention provides a kit or a device for the detection of prostate cancer, comprising a nucleic acid capable of specifically binding to a miRNA in a sample of a subject, and a method for detecting prostate cancer, comprising measuring the miRNA in vitro.
Type:
Grant
Filed:
March 3, 2020
Date of Patent:
December 6, 2022
Assignees:
TORAY INDUSTRIES, INC., NATIONAL CANCER CENTER
Abstract: It is intended to provide a kit or device for the detection of liver cancer and a method for detecting liver cancer. The present invention relates to a kit or device for the detection of liver cancer, comprising a nucleic acid capable of specifically binding to miRNA in a sample of a subject, and a method for detecting liver cancer, comprising measuring the miRNA in vitro.
Type:
Grant
Filed:
February 7, 2020
Date of Patent:
November 29, 2022
Assignees:
TORAY INDUSTRIES, INC., NATIONAL CANCER CENTER